Tag Archives: AMPE

Top Low Price Stocks To Buy For 2019

 Q: The stock market seems to be reaching new record highs every day. Are there any stocks that still look cheap?

Corporate earnings have exhibited pretty impressive growth as a whole over the past few years, so the market’s performance is somewhat justified. However, many stocks do look to be rather expensive right now — particularly in the tech sector. Yet some bargains remain.

One of my favorite “cheap” stocks right now is AT&T (NYSE: T), even after shares popped following the company’s strong quarterly report. The telecom giant pays a dividend yielding more than 5% and is a Dividend Aristocrat, meaning that it has increased its dividend for more than 25 consecutive years.

Despite a low price-to-earnings multiple of just 13 times 2017’s expected earnings, AT&T has lots of room to grow, especially thanks to its purchase of DIRECTV and its pending acquisition of Time Warner, both of which should give it an advantage over the competition when it comes to bundling services and broadcasting content directly to smartphones and tablets.

Top Low Price Stocks To Buy For 2019: Ampio Pharmaceutical(AMPE)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Ampio Pharmaceuticals (NYSEMKT:AMPE) were devastated today, dropping 71% in the first hour of trading, after the company delivered a regulatory update in a Securities and Exchange Commission filing concerning its lead drug candidate Ampion. The drug, which is being developed as a treatment for severe osteoarthritis of the knee, appeared to report positive results in a phase 3 trial at the end of 2017. But investors just learned that the data collected will not be sufficient to support regulatory approval. 

  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

  • [By Shane Hupp]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a significant increase in short interest in the month of June. As of June 29th, there was short interest totalling 14,752,101 shares, an increase of 39.8% from the June 15th total of 10,555,723 shares. Currently, 19.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,744,324 shares, the short-interest ratio is currently 8.5 days.

Top Low Price Stocks To Buy For 2019: BP Prudhoe Bay Royalty Trust(BPT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Blockport (CURRENCY:BPT) traded down 0.3% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on September 14th. One Blockport token can now be bought for $0.0819 or 0.00001261 BTC on popular cryptocurrency exchanges including Kucoin and IDEX. Over the last week, Blockport has traded down 2.3% against the U.S. dollar. Blockport has a total market cap of $4.33 million and $60,265.00 worth of Blockport was traded on exchanges in the last 24 hours.

  • [By Sean Williams]

    As a case in point, consider BP Prudhoe Bay Royalty Trust (NYSE:BPT), which is currently paying out an extrapolated $5.10 a year, based on the $1.275 per share it divvied out in April. This is good enough for a better than 17% annual yield, albeit it should be noted that the Trust’s payout differs each quarter depending on its royalty revenue and cash earnings. 

  • [By Dan Caplinger]

    Sometimes, though, you can have too much of a good thing. Dividend stocks with top dividend yields come with special risks, and although that doesn’t guarantee that you’ll get burned, the chances of a setback are greater. Below, I’ll look at BP Prudhoe Bay Royalty Trust (NYSE:BPT), CenturyLink (NYSE:CTL), and Annaly Capital Management (NYSE:NLY) to explain why their yields are so high and what dangers could lurk beneath the surface.

Top Low Price Stocks To Buy For 2019: Inphi Corporation(IPHI)

Advisors’ Opinion:

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

  • [By Timothy Green]

    Shares of Inphi Corp. (NYSE:IPHI) dropped on Wednesday following a mixed first-quarter report and a subsequent analyst downgrade. The company’s revenue declined sharply and came in just short of analyst expectations. The stock was down about 9.5% at 2:45 p.m. EDT.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Inphi (IPHI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Inphi Co. (NYSE:IPHI) – Research analysts at DA Davidson lifted their FY2018 earnings per share estimates for Inphi in a research note issued on Monday, January 28th. DA Davidson analyst M. Kelleher now anticipates that the semiconductor company will post earnings per share of ($0.63) for the year, up from their previous estimate of ($0.65). DA Davidson has a “Buy” rating and a $45.00 price objective on the stock. DA Davidson also issued estimates for Inphi’s Q1 2019 earnings at ($0.12) EPS and Q2 2019 earnings at ($0.01) EPS.

  • [By Ethan Ryder]

    Inphi Co. (NYSE:IPHI) VP Ron Torten sold 12,342 shares of Inphi stock in a transaction dated Monday, August 27th. The stock was sold at an average price of $35.00, for a total value of $431,970.00. Following the sale, the vice president now directly owns 64,386 shares of the company’s stock, valued at approximately $2,253,510. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

  • [By ]

    There are some companies that have weak fundamentals and are regularly incurring losses but that are valued strongly by the market purely based on one metric: revenue growth. Inphi Corporation (NYSE:IPHI) is the perfect example of such a company that has enjoyed a very high valuation despite being a loss-making unit for a large period within the past five years. The company’s revenue growth was phenomenal and the profits were expected soon. In fact, the company did end up with a good profit in 2016 when the EV/Sales multiple shot up above 7.

Best Heal Care Stocks To Invest In 2019

GSA Capital Partners LLP acquired a new stake in shares of HDFC Bank Limited (NYSE:HDB) in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 118,937 shares of the bank’s stock, valued at approximately $12,491,000. HDFC Bank makes up about 0.6% of GSA Capital Partners LLP’s investment portfolio, making the stock its 3rd biggest position.

Other hedge funds and other institutional investors have also modified their holdings of the company. Braun Bostich & Associates Inc. bought a new position in HDFC Bank during the 1st quarter worth approximately $102,000. Mondrian Investment Partners LTD lifted its holdings in HDFC Bank by 191.7% during the 1st quarter. Mondrian Investment Partners LTD now owns 1,750 shares of the bank’s stock worth $168,000 after buying an additional 1,150 shares during the last quarter. Barrow Hanley Mewhinney & Strauss LLC bought a new position in HDFC Bank during the 1st quarter worth approximately $168,000. Private Capital Group LLC lifted its holdings in HDFC Bank by 4,389.5% during the 1st quarter. Private Capital Group LLC now owns 1,706 shares of the bank’s stock worth $169,000 after buying an additional 1,668 shares during the last quarter. Finally, Pitcairn Co. bought a new position in HDFC Bank during the 2nd quarter worth approximately $201,000. Hedge funds and other institutional investors own 16.85% of the company’s stock.

Best Heal Care Stocks To Invest In 2019: ENSERVCO Corporation(ENSV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Enservco (NYSEAMERICAN:ENSV) will be issuing its quarterly earnings data before the market opens on Wednesday, May 9th.

    Enservco (NYSEAMERICAN:ENSV) last issued its earnings results on Thursday, March 22nd. The oil and gas producer reported ($0.04) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.01) by ($0.03). Enservco had a negative return on equity of 89.94% and a negative net margin of 43.71%. The business had revenue of $14.13 million during the quarter.

Best Heal Care Stocks To Invest In 2019: Ampio Pharmaceutical(AMPE)

Advisors’ Opinion:

  • [By Maxx Chatsko]

    Shares of Ampio Pharmaceuticals (NYSEMKT:AMPE) were devastated today, dropping 71% in the first hour of trading, after the company delivered a regulatory update in a Securities and Exchange Commission filing concerning its lead drug candidate Ampion. The drug, which is being developed as a treatment for severe osteoarthritis of the knee, appeared to report positive results in a phase 3 trial at the end of 2017. But investors just learned that the data collected will not be sufficient to support regulatory approval. 

  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

  • [By Shane Hupp]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a significant increase in short interest in the month of June. As of June 29th, there was short interest totalling 14,752,101 shares, an increase of 39.8% from the June 15th total of 10,555,723 shares. Currently, 19.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,744,324 shares, the short-interest ratio is currently 8.5 days.

Best Heal Care Stocks To Invest In 2019: Red Lion Hotels Corporation(RLH)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Red Lion Hotels (RLH)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    These are some of the media stories that may have impacted Accern Sentiment’s scoring:

    Get Red Lion Hotels alerts:

    Contrasting Hilton Worldwide (HLT) and Red Lion Hotels (RLH) (americanbankingnews.com) Red Lion Hotels Co. (RLH) Director Sells $838,969.60 in Stock (americanbankingnews.com) Insider Selling: Red Lion Hotels Co. (RLH) Director Sells 178,000 Shares of Stock (americanbankingnews.com) Red Lion Hotels Co. (RLH) Major Shareholder Sells $5,099,986.65 in Stock (americanbankingnews.com) RLH Corporation Promotes Paul Sacco to Executive Vice President, President of Global Development (finance.yahoo.com)

    Several equities analysts have recently weighed in on the company. ValuEngine upgraded Red Lion Hotels from a “buy” rating to a “strong-buy” rating in a research report on Thursday, June 7th. Zacks Investment Research upgraded Red Lion Hotels from a “sell” rating to a “hold” rating in a research report on Wednesday, May 30th.

  • [By Max Byerly]

    These are some of the media stories that may have impacted Accern’s scoring:

    Get Red Lion Hotels alerts:

    Red Lion Hotels Corporation: RLH Corporation Announces Second Quarter 2018 Earnings Conference Call to be Held August 9 (twst.com) Davenport Hotels owner buys, rebrands Hotel Red Lion at the Park (krem.com) Red Lion Hotels Corporation: RLH Corporation Closes Sale of Hotel RL Spokane at the Park for $35 Million (twst.com) Financial Comparison: Red Lion Hotels (RLH) and Wyndham Worldwide (WYN) (americanbankingnews.com)

    Shares of Red Lion Hotels traded down $0.10, hitting $12.00, during mid-day trading on Friday, according to MarketBeat Ratings. 104,271 shares of the company’s stock traded hands, compared to its average volume of 70,126. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.37 and a current ratio of 1.38. Red Lion Hotels has a 1 year low of $6.15 and a 1 year high of $12.75.

  • [By Shane Hupp]

    Red Lion Hotels (NYSE: RLH) and Wynn Resorts (NASDAQ:WYNN) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, dividends, analyst recommendations, valuation, profitability and earnings.

Top 10 High Tech Stocks For 2019

If there’s one thing Americans are unfortunately good at, it’s racking up debt, and new data from Northwestern Mutual further drives home this point. Specifically, the average level of personal debt, not including mortgages, climbed to $38,000 this year, which represents an almost $1,000 increase from 2017.

Here’s another troubling statistic: A good 20% of Americans allocate anywhere from 50% to 100% of their income to repaying debt, while 13% are convinced they’ll be in debt for the rest of their lives.

IMAGE SOURCE: GETTY IMAGES.

If the idea of being perpetually saddled with debt doesn’t sit well with you, you should know that there are steps you can take to recover. And the sooner you do, the better you’ll feel about your financial outlook on a whole.

Top 10 High Tech Stocks For 2019: State Bank Financial Corporation.(STBZ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on State Bank Financial (STBZ)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Citizens Financial Group (NYSE:CFG) and State Bank Financial (NASDAQ:STBZ) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, dividends, earnings, institutional ownership and analyst recommendations.

  • [By Logan Wallace]

    State Bank Financial (NASDAQ:STBZ) last issued its quarterly earnings results on Thursday, January 25th. The financial services provider reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.03. State Bank Financial had a return on equity of 9.26% and a net margin of 18.77%. The firm had revenue of $68.16 million during the quarter, compared to the consensus estimate of $65.00 million. analysts expect that State Bank Financial will post 2.18 EPS for the current year.

    TRADEMARK VIOLATION WARNING: “Analysts Set State Bank Financial (STBZ) PT at $34.00” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this story on another site, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The legal version of this story can be viewed at www.tickerreport.com/banking-finance/3379591/analysts-set-state-bank-financial-stbz-pt-at-34-00.html.

    State Bank Financial Company Profile

Top 10 High Tech Stocks For 2019: Broadwind Energy Inc.(BWEN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Matthews International (NASDAQ: MATW) and Broadwind Energy (NASDAQ:BWEN) are both small-cap consumer staples companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Broadwind Energy (BWEN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Matthews International (NASDAQ: MATW) and Broadwind Energy (NASDAQ:BWEN) are both small-cap consumer staples companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Top 10 High Tech Stocks For 2019: Care.com, Inc.(CRCM)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Care.com (CRCM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    Care.com, Inc. (NYSE: CRCM) shares shot up 19 percent to $18.8426 following Q1 earnings.

    Shares of ProPhase Labs, Inc. (NASDAQ: PRPH) got a boost, shooting up 54 percent to $4.4302 after the company announced a special $1.00 per share cash dividend.

  • [By Lisa Levin] Gainers
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 50.7 percent to $4.34 after the company announced a special $1.00 per share cash dividend.
    Impinj, Inc. (NASDAQ: PI) surged 28.4 percent to $17.44 after reporting Q1 results.
    Cardlytics, Inc. (NASDAQ: CDLX) gained 22 percent to $17.945.
    Care.com, Inc. (NYSE: CRCM) shares rose 19.3 percent to $18.92 following Q1 earnings.
    Sharing Economy International Inc. (NASDAQ: SEII) jumped 19.1 percent to $4.3934 after the company disclosed that it entered into a license agreement with Ecrent Capital Holdings Limited.
    Blink Charging Co. (NASDAQ: BLNK) rose 18.6 percent to $4.79 after jumping 171.14 percent on Monday.
    IntriCon Corporation (NASDAQ: IIN) climbed 17.4 percent to $29.30 after reporting Q1 results.
    Nevsun Resources Ltd. (NYSE: NSU) rose 16.2 percent to $3.45 after Lundin Mining Corporation and Euro Sun Mining Inc. proposed to acquire Nevsun Resources for around C$1.5 billion.
    Tactile Systems Technology, Inc. (NASDAQ: TCMD) gained 15.4 percent to $42.61 following Q1 results.
    eGain Corporation (NASDAQ: EGAN) gained 15.3 percent to $10.55 following Q3 earnings.
    Dean Foods Company (NYSE: DF) rose 13.8 percent to $9.48 after reporting upbeat Q1 earnings.
    Sterling Construction Company, Inc. (NASDAQ: STRL) shares surged 13.1 percent to $13.42 after reporting Q1 results.
    USA Technologies, Inc. (NASDAQ: USAT) climbed 11.9 percent to $10.85 following better-than-expected Q3 earnings.
    scPharmaceuticals Inc. (NASDAQ: SCPH) gained 11.2 percent to $14.45 following Q1 results.
    Fiesta Restaurant Group, Inc. (NASDAQ: FRGI) rose 10.2 percent to $24.08 following Q1 results.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 7.9 percent to $19.60 as the company posted upbeat Q1 results and raised its outlook.
    Carrols Restaurant Group, Inc. (NASDAQ: TAST) rose 7.7 percent to $11.90 following upbeat Q1 results.
    Pareteum Corporation (NASDAQ: TEUM) rose 6.8 perc
  • [By Logan Wallace]

    Care.com Inc (NYSE:CRCM) CFO Michael Echenberg sold 18,094 shares of Care.com stock in a transaction on Monday, October 1st. The shares were sold at an average price of $21.90, for a total transaction of $396,258.60. Following the completion of the sale, the chief financial officer now owns 46,674 shares in the company, valued at $1,022,160.60. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

  • [By Logan Wallace]

    Laurion Capital Management LP boosted its position in Care.com Inc (NYSE:CRCM) by 10.9% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 47,031 shares of the information services provider’s stock after purchasing an additional 4,633 shares during the quarter. Laurion Capital Management LP owned approximately 0.15% of Care.com worth $982,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Headlines about Care.com (NYSE:CRCM) have been trending somewhat positive recently, Accern reports. The research group rates the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Care.com earned a news impact score of 0.04 on Accern’s scale. Accern also assigned news articles about the information services provider an impact score of 46.4871932873326 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 10 High Tech Stocks For 2019: Guaranty Bancorp(GBNK)

Advisors’ Opinion:

  • [By Lisa Levin]

    Tuesday afternoon, the financial shares surged 1.13 percent. Meanwhile, top gainers in the sector included Guaranty Bancorp (NASDAQ: GBNK), up 6 percent, and Itaú Unibanco Holding S.A. (NYSE: ITUB) up 4 percent.

  • [By Logan Wallace]

    Guaranty Bancorp (NASDAQ:GBNK) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research note issued on Friday.

  • [By Logan Wallace]

    Guaranty Bancorp (NASDAQ:GBNK) – Analysts at Piper Jaffray Companies lifted their Q3 2018 EPS estimates for shares of Guaranty Bancorp in a report released on Thursday, August 9th. Piper Jaffray Companies analyst B. Rabatin now expects that the financial services provider will post earnings per share of $0.48 for the quarter, up from their prior estimate of $0.46. Piper Jaffray Companies currently has a “Hold” rating and a $32.50 target price on the stock. Piper Jaffray Companies also issued estimates for Guaranty Bancorp’s Q4 2018 earnings at $0.50 EPS, FY2018 earnings at $1.93 EPS, Q1 2019 earnings at $0.50 EPS, Q2 2019 earnings at $0.51 EPS, Q3 2019 earnings at $0.53 EPS, Q4 2019 earnings at $0.55 EPS and FY2019 earnings at $2.09 EPS.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Guaranty Bancorp (GBNK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

    On Tuesday, the financial shares surged 0.71 percent. Meanwhile, top gainers in the sector included Guaranty Bancorp (NASDAQ: GBNK), up 5 percent, and Jupai Holdings Limited (NYSE: JP) up 5 percent.

Top 10 High Tech Stocks For 2019: Diodes Incorporated(DIOD)

Advisors’ Opinion:

  • [By Shane Hupp]

    JPMorgan Chase & Co. lessened its stake in shares of Diodes Incorporated (NASDAQ:DIOD) by 67.0% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 23,610 shares of the semiconductor company’s stock after selling 47,902 shares during the period. JPMorgan Chase & Co.’s holdings in Diodes were worth $719,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Diodes Incorporated (NASDAQ:DIOD) CEO Keh Shew Lu sold 48,248 shares of the firm’s stock in a transaction dated Monday, August 27th. The shares were sold at an average price of $38.32, for a total value of $1,848,863.36. Following the sale, the chief executive officer now owns 620,304 shares in the company, valued at $23,770,049.28. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Diodes (DIOD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Money Morning Staff Reports]

    That’s a great way to cash in on the growth of technology without buying into overhyped (and overpriced) semiconductor stocks, like Diodes Inc. (Nasdaq: DIOD), which trades for 111 times earnings.

Top 10 High Tech Stocks For 2019: Omnicell Inc.(OMCL)

Advisors’ Opinion:

  • [By Shane Hupp]

    Shares of Omnicell, Inc. (NASDAQ:OMCL) have been given an average rating of “Buy” by the nine analysts that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price target among brokerages that have covered the stock in the last year is $66.40.

  • [By Shane Hupp]

    Omnicell Technologies (NASDAQ:OMCL) insider Robin Gene Seim sold 13,286 shares of the firm’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $46.48, for a total value of $617,533.28. Following the completion of the transaction, the insider now directly owns 74,121 shares in the company, valued at $3,445,144.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Omnicell Technologies (OMCL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Omnicell Technologies (NASDAQ:OMCL) insider Peter J. Kuipers sold 724 shares of the company’s stock in a transaction dated Thursday, April 12th. The shares were sold at an average price of $46.00, for a total value of $33,304.00. Following the completion of the sale, the insider now directly owns 56,970 shares of the company’s stock, valued at $2,620,620. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

Top 10 High Tech Stocks For 2019: American Airlines Group, Inc.(AAL)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    It can’t be fun to be American Airlines (NASDAQ:AAL) CEO Doug Parker right now. His company has experienced massive nonfuel cost increases over the past few years. Now that the carrier is finally reining in controllable costs, fuel prices have surged, creating a new headache. Meanwhile, American has the weakest balance sheet of any major U.S. airline.

  • [By Paul Ausick]

    American Airlines Group Inc. (NASDAQ: AAL) traded down about 1.5% Tuesday to post a new 52-week low of $36.77 after closing Monday at $38.36. The stock’s 52-week high is $59.08. Volume was about 15% below the daily average of around 6.2 million shares. The company had no specific news.

  • [By Chris Lange]

    The S&P 500 stock posting the largest daily percentage loss ahead of the close Tuesday was American Airlines Group Inc. (NASDAQ: AAL) which traded down about 4.5% at $47.57. The stock’s 52-week range is $42.01 to $59.08. Volume was nearly 13 million compared to the daily average volume of nearly 5 million.

  • [By Adam Levine-Weinberg]

    Not surprisingly, the airlines with the lowest profit margins have been hit hardest. These carriers are the most vulnerable to fuel price increases and demand shocks, as small changes in their profit margins can severely impact their earnings. During the past year, American Airlines (NASDAQ:AAL) has fallen into the bottom echelon of U.S. airlines in terms of profitability, and so its share price tumbled 7.5% in the first three days of this week.

Top 10 High Tech Stocks For 2019: Dawson Geophysical Company(DWSN)

Advisors’ Opinion:

  • [By Max Byerly]

    Dawson Geophysical (NASDAQ:DWSN) was downgraded by equities researchers at ValuEngine from a “buy” rating to a “hold” rating in a research note issued on Monday.

  • [By Logan Wallace]

    Dawson Geophysical (NASDAQ:DWSN) was upgraded by stock analysts at TheStreet from a “d+” rating to a “c-” rating in a research note issued on Monday.

Top 10 High Tech Stocks For 2019: Ampio Pharmaceutical(AMPE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

  • [By Shane Hupp]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a significant increase in short interest in the month of June. As of June 29th, there was short interest totalling 14,752,101 shares, an increase of 39.8% from the June 15th total of 10,555,723 shares. Currently, 19.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,744,324 shares, the short-interest ratio is currently 8.5 days.

  • [By Maxx Chatsko]

    Shares of Ampio Pharmaceuticals (NYSEMKT:AMPE) were devastated today, dropping 71% in the first hour of trading, after the company delivered a regulatory update in a Securities and Exchange Commission filing concerning its lead drug candidate Ampion. The drug, which is being developed as a treatment for severe osteoarthritis of the knee, appeared to report positive results in a phase 3 trial at the end of 2017. But investors just learned that the data collected will not be sufficient to support regulatory approval. 

Top 10 High Tech Stocks For 2019: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Attunity Ltd (NASDAQ:ATTU) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $12.33.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Insurance Stocks To Buy Right Now

Tim Melvin

I spend a lot of time every week scanning and searching the market (using a wide range of tools) for stocks that are unreasonably underpriced.

One of those tools that I faithfully review is the Money Morning Stock VQScoreTM. Stocks with the highest VQScore have done very well historically, and their approach finds stocks positioned for liftoff soon. And that’s just one of the tools I use every week.

This week, I ran across Tiptree Inc. (Nasdaq: TIPT) on the list of stocks with the highest VQScores. Tiptree fits most of my parameters as well so I spent a little time digging into the company further.

Tiptree is an exciting company that combines a specialty insurance operation with management’s investing experience. And this stock has the prospects for extraordinary returns for patient, aggressive investors.

Top Insurance Stocks To Buy Right Now: Ampio Pharmaceutical(AMPE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a significant increase in short interest in the month of June. As of June 29th, there was short interest totalling 14,752,101 shares, an increase of 39.8% from the June 15th total of 10,555,723 shares. Currently, 19.0% of the company’s stock are short sold. Based on an average daily trading volume, of 1,744,324 shares, the short-interest ratio is currently 8.5 days.

  • [By Ethan Ryder]

    Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 10,472,904 shares, a drop of 6.6% from the May 15th total of 11,209,042 shares. Based on an average daily trading volume, of 806,646 shares, the days-to-cover ratio is currently 13.0 days. Currently, 13.5% of the shares of the company are sold short.

Top Insurance Stocks To Buy Right Now: Oritani Financial Corp.(ORIT)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Oritani Financial (ORIT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Aperio Group LLC lifted its stake in shares of Oritani Financial Corp. (NASDAQ:ORIT) by 21.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,930 shares of the bank’s stock after acquiring an additional 9,276 shares during the quarter. Aperio Group LLC owned 0.11% of Oritani Financial worth $797,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Customers Bancorp (NYSE: CUBI) and Oritani Financial (NASDAQ:ORIT) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership.

Top Insurance Stocks To Buy Right Now: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

  • [By Joseph Griffin]

    These are some of the news headlines that may have effected Accern Sentiment Analysis’s scoring:

    Get Insys Therapeutics alerts:

    Chemotherapy Induced Nausea and Vomiting – Pipeline Insight, 2018 Market Report; Launched via MarketResearchReports.com (digitaljournal.com) Insys Therapeutics (INSY) Presents At Jefferies 2018 Global Healthcare Conference – Slideshow (seekingalpha.com) Insys Therapeutics (INSY) Expected to Announce Quarterly Sales of $27.32 Million (americanbankingnews.com) INSYS Therapeutics, Inc. (INSY)- Price to Book (P/B) Ratio in the Limelight (nasdaqfortune.com) INSYS Therapeutics to Present at Jefferies Global Healthcare Conference (globenewswire.com)

    Shares of NASDAQ:INSY traded up $0.09 during mid-day trading on Monday, reaching $6.96. The stock had a trading volume of 19,958 shares, compared to its average volume of 602,835. The company has a market capitalization of $507.07 million, a P/E ratio of -14.20 and a beta of 1.09. Insys Therapeutics has a 1 year low of $4.10 and a 1 year high of $14.00.

  • [By ]

    Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

  • [By Sean Williams]

    Yet in spite of this momentum, drug developer Insys Therapeutics (NASDAQ:INSY) has been an absolute train wreck. Insys offers a broad spectrum of therapies in its product portfolio and pipeline, but it gets its association with “marijuana stocks” through its Food and Drug Administration (FDA) approval of Syndros, a liquid dronabinol solution — i.e., a synthetic form of tetrahydrocannabinol (THC), the psychoactive component of the cannabis plant — designed to treat chemotherapy-induced nausea and vomiting, as well as anorexia associated with AIDS. It also has other cannabidiol-based products in development in its pipeline.

  • [By Brian Orelli]

    Shares of Insys Therapeutics(NASDAQ:INSY) rose 11% in June, according to data provided byS&P Global Market Intelligence. While the biotech is most famous for its opioid painkiller Subsys as well as Syndros, which is based on a compound in marijuana, it was clinical trial datafrom a new product that has investors excited.